Listar por título
Mostrando ítems 1609-1628 de 2964
-
La gestión de los viajeros enfermos en los puntos de entrada –aeropuertos, puertos y pasos fronterizos terrestres internacionales– en el contexto del brote de COVID-19, Directrices provisionales, 16 de febrero de 2020
En virtud del Reglamento Sanitario Internacional (RSI), las autoridades de salud pública de los puertos, aeropuertos y pasos fronterizos terrestres internacionales deben establecer planes y medidas de contingencia eficaces ... -
La médecine chinoise pour le traitement du SARS
(2020-04-14)Citation: Leung, PC. The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis. American Journal of Chinese Medicine 2007; 35(4): 575-81 De quoi s’agit-il ? Comme le COVID-19, le syndrome ... -
Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) Interim guidance 12 February 2020
The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of the novel pathogen identified in Wuhan, China, ... -
Laboratory Guidelines for Detection and Diagnosis of the Novel Coronavirus (2019-nCoV) Infection, February 01, 2020
(2020-02-01)Coronaviruses are a group of highly diverse RNA virus in the Coronaviridae family that are divided in 4 genera: alpha, beta, gamma and delta that cause disease varying from mild to severe in human and animals. There are ... -
Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection, 8 July 2020
(2020-07-08)In January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as being a novel betacoronavirus, distinct from SARS-CoV and MERS-CoV. On 11 February 2020, the ... -
Laboratory infection with Zika virus after vaccination against yellow fever
(2014)One of the authors contracted a Zika virus infection during laboratory work. Subsequent studies revealed an immunological response of the anamnestic type due to preceding yellow fever vaccinations which rendered difficult ... -
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories
(2020)Background & objectives: An outbreak of respiratory illness of unknown aetiology was reported from Hubei province of Wuhan, People's Republic of China, in December 2019. The outbreak was attributed to a novel coronavirus ... -
Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases, Interim guidance, 2 March 2020
Overview. The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a ... -
Laparoscopic Surgery and the debate on its safety during COVID-19 pandemic: A systematic review of recommendations
(2020-08-11)Introduction: The transmission of COVID-19 virus since the outbreak of viral pneumonia due to SARS-CoV-2 gave rise to protective operative measures. Aerosol generating procedures such as laparoscopic surgery are known to ... -
Laparoscopic surgery in COVID-19 Era—Safety and Ethical Issues
(2020)Background: The paper aims to review the available evidence regarding the health risk of the aerosolization induced by laparoscopy induced and impact of the COVID-19 pandemic upon minimally invasive surgery. (2) Materials ... -
Large-scale implementation of pooled RNA-extraction and RT-PCR for SARS-CoV-2 detection
(2020-05-07)Testing for active SARS-CoV-2 infection is a fundamental tool in the public health measures taken to control the COVID-19 pandemic. Due to the overwhelming use of SARS-CoV-2 RT-PCR tests worldwide, availability of test ... -
The Latin American and Caribbean Climate Landscape for ZIKV Transmission
(2016)This document presents a short review of the basic climate of Latin America and the Caribbean (LAC), focusing on the rainfall and temperature regional differences at multiple timescales, and where present climate forecasts ... -
Le CReSP répond à vos questions
(2020-09-02)Afin de répondre aux questions de santé publique en lien avec la pandémie de la COVID-19, le CReSP a mis en place un bulletin d’information à destination des praticiens et des gestionnaires du système de santé publique qui ... -
Le programme de vaccination dans le contexte de la pandémie de COVID-19 (26 mars 2020) Objectif
(2020-03-26)En décembre 2019, un nouveau coronavirus (SARS-CoV-2) a été identifié comme l’agent causal d’une maladie respiratoire aiguë grave (la COVID-19) à Wuhan (Chine). Le virus s’est propagé à divers pays et l’Organisation mondiale ... -
Learning from the past: did experience with previous epidemics help mitigate the impact of COVID-19 among spine surgeons worldwide?
(2020-06-04)Purpose: Spine surgeons around the world have been universally impacted by COVID-19. The current study addressed whether prior experience with disease epidemics among the spine surgeon community had an impact on preparedness ... -
Les antibiotiques atypiques à eux seuls ne semblent pas être préférables en terme de mortalité et d’efficacité clinique que les antibiotiques typiques uniquement chez les patients atteints d’une pneumonie acquise dans la communauté
(2020-03-28)Citation: Eliakim-Raz N, Robenshtok E, Shefet D, et al. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012; (9): CD004418. ... -
Les antibiotiques chez les enfants atteints de pneumonie acquise en communauté
(2020-04-02)Citation: Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database of Systematic Reviews 2013; (6): CD004874 De quoi s’agit-il? Certains patients atteints du COVID-19 ... -
Les colloïdes et les cristalloïdes peuvent avoir des effets semblables sur la mortalité quand ils sont utilisés pour la substitution de liquide chez les patients gravement malades
(2020-03-27)Citation: Lewis SR, Pritchard MW, Evans DJW, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database of Systematic Reviews 2018; (8): CD000567. De quoi s’agit-il ? Certains ...